Chemours Files Proxy Statement for Annual Shareholder Meeting
Ticker: CC · Form: DEFA14A · Filed: Apr 14, 2025 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | DEFA14A |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, shareholder-vote
Related Tickers: CC
TL;DR
Chemours filed its proxy statement, shareholders need to vote for the annual meeting.
AI Summary
The Chemours Company (Chemours) has filed a Definitive Proxy Statement (DEFA14A) for its Annual Meeting of Shareholders. The filing indicates that the company is seeking shareholder votes on various matters, as is standard for proxy statements. The document was filed on April 14, 2025.
Why It Matters
This filing is crucial for shareholders as it outlines the proposals and information needed to cast their votes on important company matters at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a standard proxy filing for an annual shareholder meeting, not indicating any unusual or high-risk events.
Key Players & Entities
- The Chemours Company (company) — Registrant
- 0001104659-25-034744 (filing_id) — Accession Number
- 20250414 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for The Chemours Company?
This is a Definitive Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934.
When was this filing made?
The filing was made on April 14, 2025.
What is the Central Index Key (CIK) for The Chemours Company?
The CIK for The Chemours Company is 0001627223.
What is the primary purpose of a DEFA14A filing?
A DEFA14A filing is used to solicit shareholder votes for an upcoming meeting, providing information on proposals, director nominees, and other relevant corporate governance matters.
Where is The Chemours Company headquartered?
The Chemours Company's business address is 1007 Market Street, Wilmington, DE 19801.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 14, 2025 regarding Chemours Co (CC).